How to Get Wegovy Online in Setúbal

Are you looking to get a Wegovy prescription online in Setúbal? You can now access EU-licensed doctors for a remote consultation through Hi-Doctor. We provide a straightforward, secure, and fast way to potentially receive your Wegovy prescription without a clinic visit. For just €25, an EU-licensed doctor reviews your case, and if appropriate, a prescription is issued in under 24 hours. It's valid at any pharmacy in the EU, including Portugal.

How it works — get your Wegovy prescription in 4 steps

1. Complete your online medical questionnaire (2–3 minutes) and pay the €25 consultation fee. This provides the doctor with all necessary information about your health and medical history.
2. A licensed EU doctor reviews your case privately. They assess your eligibility for Wegovy based on your medical information. If the doctor determines the treatment is not appropriate for you, your €25 fee is refunded automatically – you pay nothing. There is no risk.
3. If approved, you receive a REMPE electronic prescription (PDF file) in your Hi-Doctor account and by email within 24 hours. This is Spain's official digital private prescription standard.
4. Print the PDF or show it on your phone – present it at any pharmacy in the EU to collect Wegovy. This includes pharmacies throughout Setúbal and the rest of Portugal.

Who qualifies for Wegovy

Wegovy (semaglutide) is a prescription-only medication for chronic weight management. Doctors look for specific criteria to ensure it's safe and effective for you. Generally, you may qualify if you have a Body Mass Index (BMI) of 30 kg/m² or greater (obesity), or a BMI of 27 kg/m² or greater (overweight) with at least one weight-related comorbidity such as high blood pressure, type 2 diabetes, or high cholesterol. The reviewing doctor will consider your full medical history and current health status to determine if Wegovy is appropriate for you. They will also check for contraindications like a personal or family history of medullary thyroid carcinoma or Multiple Endocrine Neoplasia syndrome type 2 (MEN 2).

What Wegovy actually does (and doesn't do)

Wegovy is a GLP-1 receptor agonist. It works by mimicking a natural hormone in your body that targets areas of the brain involved in appetite regulation. This helps you feel fuller, reduce your food intake, and ultimately lose weight. It's an aid to weight management, not a standalone solution. For best results, it should be used in conjunction with a reduced-calorie diet and increased physical activity. Weight loss is gradual and varies among individuals; it is not a 'quick fix' and requires consistent use as prescribed by your doctor.

Side effects and when to stop

Like all medications, Wegovy can cause side effects. The most common are gastrointestinal, including nausea, diarrhea, vomiting, and constipation, especially when starting treatment or increasing the dose. These usually lessen over time. Less common but more serious side effects include pancreatitis, gallbladder problems, kidney problems, and allergic reactions. Your doctor will discuss these with you. You should contact your doctor immediately if you experience severe abdominal pain, persistent vomiting, or symptoms of a serious allergic reaction. If side effects are intolerable or concerning, the doctor will advise on whether to adjust your dosage or discontinue treatment.

Why Hi-Doctor vs. walking into a clinic

• Speed: Get your prescription in <24 hours online, compared to potentially weeks for an in-person appointment.
• Price: A flat €25 consultation fee, with a money-back guarantee if not approved. Traditional clinics often have variable and higher consultation costs.
• Privacy: Everything happens in your secure Hi-Doctor account – no waiting rooms, no reception desks, complete discretion.
• Convenience: Consult from anywhere in Setúbal or beyond, using your phone or computer. No travel, no time off work.
• Trust: Join over 50,000 patients served with a 4.8-star Trustpilot rating. Our EU-licensed doctors provide secure, RGPD-compliant care.